Serine
In clinical developmentAlso known as (S)-2-Amino-3-hydroxypropanoic acid, (S)-Serine, Aminosyn 10%, Sulfite-Free, Aminosyn 3.5 % M, Sulfite Free+40 more
(S)-2-Amino-3-hydroxypropanoic acid, (S)-Serine, Aminosyn 10%, Sulfite-Free, Aminosyn 3.5 % M, Sulfite Free, Aminosyn 8.5 % with Electrolytes, Sulfite-Free, Aminosyn 8.5%, Sulfite-Free, Aminosyn II 10 %, Aminosyn II 15%, Aminosyn II 8.5 % with Electrolytes, Sulfite-Free, Aminosyn II 8.5 %, Sulfite-Free, Aminosyn-HBC 7 %, Sulfite-Free, Aminosyn-PF 10 %, Sulfite-Free, Aminosyn-PF 7%, Clinisol 15, Freamine III 10, Hepatamine 8, Hepatasol, L-Serine, Plenamine, PremaSol, ProSol, ProcalAmine 3, Ser, Travasol 10, Travasol 10%, Trophamine, Trophamine 10 %, Trophamine 6 %, alpha-Amino-beta-hydroxypropionic acid, beta-Hydroxyalanine, Serina, Clinimix 4.25/10, Clinimix 4.25/25, Clinimix 4.25/5, Clinimix 5/15, Clinimix 5/20, Clinimix 5/25, Clinimix E 2.75/5, Clinimix E 4.25/10, Clinimix E 4.25/5, Clinimix E 5/15, Clinimix E 5/20, Clinimix E 5/25, Serinum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Phase 3 Study of Serine Supplementation to Protect Vision in MacTel
A lactate-dependent shift of glycolysis mediates synaptic and cognitive processes in male mice.
Astrocytes enhance plasticity response during reversal learning.
Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Phase 3 Study of Serine Supplementation to Protect Vision in MacTel
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Cancer research2
- Cellular and molecular life sciences : CMLS1
- Communications biology1
- Frontiers in immunology1
- Nature communications1
- Ackroyd JJ1
- Awad D1
- Barros LF1
- Bellocchio L1
- Bohmbach K1
- Bolaños JP1
- Bollmohr N1
- Bonvento G1
- Baylor College of Medicine1
- Caryl and Israel Englander Institute for Precision Medicine1
- Center for Nuclear Receptors and Cell Signaling1
- Centre de Résonance Magnétique des Systèmes Biologiques1
- CERVO Brain Research Center and Department of Biochemistry1
- Dan L. Duncan Cancer Center1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 4 of the same disease areas as Serine in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials